TLP Group’s vTv Therapeutics VTVT Stock Holding History

TLP Group’s Portfolio VTVT Stock Details VTVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-291	Closed	-$84K	–	384
2016 Q3	$84K	Buy	+291	New	+$70.1K	0.09%	225

Other funds holding VTVT

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

GTC

Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

WSA

Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

TLP Group's VTVT Position: Q4 2016 in Review

TLP Group sold out of vTv Therapeutics (VTVT) in Q4 2016, closing a stake of 291 shares — an estimated $84K sold.

TLP Group first reported a position in VTVT in Q3 2016 and held it in 1 quarter. The position peaked at $84K in Q3 2016. 44 funds tracked by Wall St. Rank hold VTVT as of Q4 2016.

TLP Group reported no remaining vTv Therapeutics position as of Q4 2016 after selling out during the quarter.
TLP Group sold 291 vTv Therapeutics shares in Q4 2016, an estimated $84K.
TLP Group first reported a position in vTv Therapeutics in Q3 2016 and held it in 1 quarter.
TLP Group's vTv Therapeutics position peaked at $84K in Q3 2016.
44 funds tracked by Wall St. Rank held vTv Therapeutics as of Q4 2016.

Based on TLP Group's 13F filing for Q4 2016, filed 2 Feb 2017.